Literature DB >> 10840280

Cryopreservation of viable human glioblastoma xenografts.

H M Goike1, A C Asplund, E H Pettersson, L Liu, K Ichimura, V P Collins.   

Abstract

Human tumour xenografts maintained in nude mice are a valuable research tool. The passaging and maintenance of human tumour xenografts in immune-deficient animals are expensive and labour-intensive. This study presents a protocol that permits long-term cryopreservation of viable glioblastoma xenograft tissue pieces in liquid nitrogen. Twenty different human glioblastoma xenografts that have been successfully transplanted and repeatedly passaged in nude mice were cryopreserved to validate the method. Different passages were cryopreserved for up to 40 months. On retransplantation of the tumours, all cases except one grew successfully. In order to ensure that the individual tumours did grow (not induced mouse tumours) restriction fragment length polymorphism analysis with variable number of tandem repeats (VNTR) probes was carried out. The method permits the long-term storage of viable, retransplantable glioblastoma xenografts. It minimizes animal use for the maintenance of xenografts and permits cryo-back-up of valuable tumours, thus markedly reducing the cost and increasing the accessibility of human tumour xenografts as a research tool in biology and genetics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840280     DOI: 10.1046/j.1365-2990.2000.026002172.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  4 in total

1.  Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

Authors:  Magdalena Ciezka; Milena Acosta; Cristina Herranz; Josep M Canals; Martí Pumarola; Ana Paula Candiota; Carles Arús
Journal:  J Neurooncol       Date:  2016-06-21       Impact factor: 4.130

2.  Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma.

Authors:  Makoto Nakagawa; Masayuki Yamaguchi; Makoto Endo; Yukino Machida; Ayuna Hattori; Fumie Tanzawa; Shinji Tsutsumi; Issay Kitabayashi; Akira Kawai; Fumihiko Nakatani
Journal:  J Bone Oncol       Date:  2022-04-16       Impact factor: 4.491

3.  Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.

Authors:  Agnieszka Cseh; Scott Owen; Scheryll Alken; Jad Alshami; Marie-Christine Guiot; Petr Kavan; David A Reardon; Thierry Muanza; Neil Gibson; Karine Pemberton; Flavio Solca; Frank Saran
Journal:  Onco Targets Ther       Date:  2022-04-08       Impact factor: 4.147

4.  Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.

Authors:  Christina Susanne Mullins; Björn Schneider; Florian Stockhammer; Mathias Krohn; Carl Friedrich Classen; Michael Linnebacher
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.